The Effect of Music on Preterm Infant's Brain Development
Launched by PEDIATRIC CLINICAL RESEARCH PLATFORM · Sep 27, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how listening to music can help the brain development of premature infants. Researchers want to see if music can make a positive difference in the way these babies' brains grow and function. To do this, they will use special imaging called MRI and other assessments to track the babies' progress.
To participate in the study, infants must be born between 33 and 37 weeks of pregnancy (which is considered preterm) or be full-term babies born between 37 and 42 weeks. However, babies with certain neurological issues or those who are currently using a type of breathing support called nCPAP will not be eligible. If your baby qualifies, they will be invited to listen to music during the study, and the researchers will monitor their brain development over time to see how it affects them. This research could lead to better care for premature infants in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Preterm infants: 33 weeks \< gestational age \< 37 weeks
- • Full-term newborns: 37 weeks gestational age \< 42 weeks
- Exclusion Criteria:
- • Neurological issues or malformations (such as III-IV stade Intraventricular hemorrhage, micro or macrocephaly, hydrocephaly...)
- • Because of the high noise caused by nasal continuous positive airway pressure (nCPAP), preterm newborns without at least nCPAP pause before 32 6/7 gestational age will be excluded
About Pediatric Clinical Research Platform
The Pediatric Clinical Research Platform is dedicated to advancing healthcare for children by facilitating innovative and ethical clinical trials tailored to pediatric populations. Our platform connects researchers, healthcare professionals, and families, ensuring that studies are designed with the unique physiological and developmental needs of children in mind. We prioritize safety and efficacy while fostering collaboration across stakeholders to accelerate the discovery of new treatments and interventions. With a commitment to transparency and rigorous scientific standards, we strive to enhance the understanding of pediatric medicine and improve health outcomes for young patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Geneva, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials